Priority Date: 19.12.11 (WO 2011SE51538)

USE OF CHEMICALLY MODIFIED HEPARIN DERIVATES IN SICKLE CELL DISEASE

  • Application ID: EP12859384
  • Status: EXAMINATION IN PROGRESS

Attorney

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C08 (ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON). We found, that TransMIT GmbH, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, Isenbruck Bösl Hörschler LLP, Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB and 43 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 19.12.2011 - Priority Date (WO 2011SE51538)
  • 27.06.2013 - Publication A1 (WO2013095277)
  • 29.10.2014 - Publication A1 (EP2794666)

IPC Classification